Owing to their imbalance expression levels in tumor cells and their capability to regulate MOMP, Bcl-2 proteins have been viewed as promising therapeutic targets in cancer and research efforts have lately been focusing on the development of drugs targeting Bcl-2 proteins. Here, BCL2 is linked to cancer.